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We report on pediatric patient with Nijmegen breakage syndrome (NBS), a rare DNA repair disorder characterized
by microcephaly, immunodeficiency and predisposition to malignant lymphomas, who developed juvenile
idiopathic arthritis (JIA)-like polyarthritis. In patients with primary immunodeficiencies (PID), septic arthritis due to
pyogenic bacteria or mycoplasmal arthritis are the most common osteoarticular manifestations. In certain PID,
chronic, non-infectious arthritis resembling rheumatoid arthritis may occur. In our patient microbiologic cultures of
synovial fluid including Mycoplasma spp. were negative. At first, because of suspected mycoplasmal arthritis we
used macrolides and doxycycline combined with hydroxychloroquine but without therapeutic response. However,
the use of rituximab led to remission of her polyarthritis lasting for 9 months. Autoimmune features were rarely
reported in NBS. An occurrence of JIA-like, chronic polyarthritis in NBS, a DNA repair disorder characterized by
decreased tolerance of immunosuppressive drugs such as methotrexate and a high natural risk for lymphomas,
makes therapeutic approach even more complex.
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Nijmegen breakage syndrome (NBS) is a rare autosomal
recessive DNA repair disorder characterized by micro-
cephaly, immunodeficiency and cancer [1,2]. NBS is due
to hypomorphic mutations of NBS1 gene, encoding less
functional nibrin, a protein involved in the repair of
DNA double-strand breaks and in cell cycle checkpoints
[3]. Albeit NBS has been reported in different ethnic
groups, more than 90% of affected persons are of Slavic
origin (Central-East Europe) and they carry homozygous
founder mutation, a 5- base-pair deletion 657del5 [4].
In NBS, congenital osteoarticular malformations such as
clinodactyly, polydactyly or syndactyly are the most com-
mon occuring in one-half of the patients. Hydronephrosis,
hypoplastic kidney, anal atresia/stenosis, CNS malforma-
tions or gonadal failure are less commonly observed [2,4].
In several other primary immunodeficiencies (PID)
non-infectious, chronic polyarthritis resembling rheuma-
toid arthritis (RA) or juvenile idiopathic arthritis (JIA)
has been reported [5-7].* Correspondence: pasics@ikomline.net
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reproduction in any medium, provided the orWe report a JIA-like, chronic polyarthritis in a female
patient with NBS.Case report
This 12-year-old girl of Slavic origin is the first child of
healthy, unrelated parents. During neonatal period intra-
uterine growth retardation (birth weight, 2700 grams)
and microcephaly (head circumference, HC = 31 cm; < p3)
were observed. Her past medical history revealed that she
suffered from recurrent lung infections (otitis media,
pneumonia) since infancy. At 18 months of age she was
treated for bacterial meningitis. At 8 years of age she was
hospitalized because of severe varicella complicated with
pneumonia. At the same age she had an episode of hip
pain diagnosed as transitory synovitis.
At 9 years of age she was referred to our Institute for
investigation of repeated lung infections. Physical exam-
ination on admission included: height, 129 cm (p50) and
the body weight, 29 kg (p50); microcephaly (head cir-
cumference = 46 cm, < p3); typical facial features with
prominent midface, large ears and hyperthelorism with
upward slant of the palpebral fissures (Figure 1); hypo-
pigmented spots on trunk and extremities; bilateral cli-
nodactyly and syndactyly of the second and third toed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Microcephaly and typical bird-like appearance in
our patient.
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http://www.ijponline.net/content/39/1/59were observed. Chest examination revealed bilateral basilar
crackles due to bronchiectasis. Neurological examination
and ophtalmologic slit-lamp examination were normal.
Immunologic investigations are presented in Table 1.
Karyotype of peripheral blood lymphocytes revealed typical
chromosomal rearrangements involving chromosomes 7
and 14. Final diagnosis of NBS was established by mutation
analysis of the NBS1 gene that revealed homozygousity
for typical 5 base-pair deletion (657del5). She was placed





IgE (IU/ml) < 50





CD3-CD16 + C56+ (NK-cellsa) 665




a NK-cells – natural killer; b IgG trough level during replacement therapy with IVIG; c(IVIG) in a dose of 400 milligrams/kg/body weight every
4 weeks. With this treatment acute exacerbations of her
chronic lung disease decreased in frequency.
At 10 years of age she was admitted because of pain,
morning stiffness and bilateral swelling of her proxymal
interphalangeal (PIP), wrist and knee joints (Figure 2).
Affected joints were hot, swollen and tender on passive
or active motion. L Laboratory investigations at that time
included: erythrocyte sedimentation rate 42 mm/hr, C-
reactive protein 92 mg/l (normal < 5 mg/l), hemoglobin
121 g/l, WBC count 6.2 × 109/l with 58% of neutrophils,
30% of lymphocytes and 6% of monocytes, platelets were
346 × 109/l; urinalysis was normal; liver function tests was
normal; serum lactate-dehydrogenase was not increased;
serum concentrations of complement components C3,
1.99 g/l and C4, 0.46 g/l both were increased. Immunologic
investigations including serum immunoglobulin concentra-
tions, peripheral blood lymphocyte phenotype and prolifer-
ative response of lymphocytes to mitogen are presented in
Table 1. Antinuclear antibodies, anti-double stranded DNA,
anti-cyclic citrullinated protein antibodies and rheumatoid
factor (RF) were all negative.
Diagnostic puncture of knee joint was done and 4 mil-
liliters of cloudy, yellow sinovial exudate was obtained.
Microscopic examination and bacterial culture of joint
fluid specimen yielded no microogranism. Also, special
cultures for Mycoplasma spp., Ureaplasma urealyticum
and mycobacteria were negative.
An initial treatment included non-steroidal anti-inflam
matory drug (NSAID) meloxicam together with azithro-
mycin because of suspected mycoplasmal infection. After
two months of treatment, no improvement was seen so
that azithromycin was replaced for doxycycline in a daily
dose of 4 mg/kg/body weight and with this treatment her













Figure 2 Symmetrical arthritis of proximal interphalangeal,
metacarpophalangeal and radiocarpal joints (also, note vitiligo).
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so hydroxychloroquine as disease-modifying antirheumatic
drug (DMARD) was given.
After one year of treatment no objective improvement
of polyarthritis using defined core set of six variables for
JIA (physician global assessment of disease activity; parent
global assessment of disease activity; number of joints
with active arthritis; number of joints with limited range
of motion; child health assessment questionaiire, erythro-
cyte sedimentation rate) was observed [8,9].
We decided to introduce rituximab in a standard dose
regimen (375 mg/m2/month) used in children and adults
affected with PID who developed autoimmune diseases
[10]. She received six infusions of rituximab without major
side-effects and continued to receive regular IVIG therapy.
Treatment with rituximab led to complete clinical and la-
boratory remission of her polyarthritis lasting for 9 months
(Table 2).
Discussion
Microcephaly, immunodeficiency and predisposition for
lymphoma at an early age are the hallmarks of NBS
[2,4]. Other commonly associated features in NBS include
skin manifestations such as café-au-lait spots, vitiligo,Table 2 Assessment of disease activity using six
defined variables




Physician VAS 68 10
Parental VAS 73 8
N of joints with active arthritis 15 0
N of joints with limited range of motion 12 3
CHAQ 2.25 1.25
Erythrocyte sedimentation rate (mm/hr) 80 12telangiectasia, flat haemangiomas or sun sensitivity of the
eyelids [2,4]. Also, congenital malformations such as
clinodactyly or syndactyly of the II/III toes are common
occuring in one-half of the patients.
Inflammatory, JIA-like polyarthritis has been reported
so far in the single Argentinian patient of Hungarian ori-
gin with NBS [11]. Similar to our patient, in Argentinian
patient the course of arthritis resembled polyarticular
onset JIA, symmetrically affecting small and large joints.
In humoral PID, such as X-linked agammaglobulinaemia
(XLA) or common variable immunodeficency (CVID), sep-
tic arthritis caused with pyogenic bacteria (S.aureus, S.
pneumoniae, H.influenzae type b) is the most common
osteoarticular manifestation [12]. Infectious arthritis in
patients with humoral PID may be also caused with
Mycoplasma spp. and U.urealyticum [12]. Colonisation
of mycoplasmal species in these patients is facilitated
because of the lack of secretory antibodies at mucosal
surfaces, and these organisms easily spread to synovial
fluid. Also, patients with XLA or CVID may remain sus-
ceptible to mycoplasmal infection even after introduction
of regular IVIG therapy because commercial IVIG lots do
not contain sufficient titers of specific antibodies against
Mycoplasma spp.
In patients with PID, differentiating non-infectious arth-
ritis from mycoplasmal infection represents a problem,
because culturing of these microorganisms may be diffi-
cult. In originally reported patient with NBS and poly-
arthritis analysis of synovial fluid was not done [11]. Furr
et al. reported mycoplasmal infection in 8 (38%) of 23 pa-
tients with hypogammaglobulinaemia and arthritis [13]. In
our patient analysis of synovial fluid showed characteris-
tics of exudate but microbiologic investigations was nega-
tive. At first, we treated our patient with macrolides and
doxycycline but without therapeutic response.
In a subset of patients with NBS, similar to CVID, im-
munodeficiency is characterized with lymphopenia asso-
ciated with a state of “immune dysregulation” leading to
autoimmunity [14]. Opposite to CVID, autoimmune dis-
orders such as autoimmune hemolytic anemia, throm-
bocytopenia or polyarthritis were rarely reported in NBS
[4,11]. In approximately 20% of patients with CVID, a
spectrum of autoimmune disorders can arise, with auto-
immune cytopenias being the most common, followed with
RA, pernicious anemia, primary biliary cirrhosis, thyroiditis,
sicca syndrome, systemic lupus or inflammatory bowel dis-
ease, respectively [15]. In a subset of patients with granu-
lomatous form of CVID characterized with lymphopenia,
autoimmune disorders, including rheumatoid-like arthritis,
were even more common, occurring in more than one-half
of patients [7]. In CVID, low proportions of CD4 +CD25+,
Foxp3 T regulatory cell subset correlated with presence of
autoimmunity and splenomegaly [16]. In patients with NBS
regulatory T cells so far were not investigated.
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led to short-term improvement of arthritis. Hydroxychloro-
quine was the most commonly used in patients with CVID
who developed rheumatoid-like arthritis or systemic lupus
[7]. In a few patients with PID presenting with non-in
fectious arthritis an introduction of regular IVIG therapy
was effective controlling articular symptoms [12]. By con-
trast, our and originally reported patient both experienced
relapses of severe polyarthritis while receiving regular treat-
ment with IVIG [11].
In CVID, cautious use of steroids has been employed
for treatment of various autoimmune features including
arthritis [6,7]. Rosenzweig et al. also observed an initial
improvement of JIA-like arthritis in NBS patient using
prednisone [11]. We were reluctant to commence ste-
roids because of the risk for severe infections. The use of
low-dose methotrexate, a DMARD with well established
safety and efficacy in children with JIA, was considered in
Argentinian patient with NBS [11]. However, previously
reported patients with NBS treated for malignancy showed
reduced tolerance to methotrexate, alkylating agents,
epipodophilotoxines and anthracyclines [17,18]. Therefore,
we believe that prolonged use of methotrexate would not
be a safe option in NBS patients with arthritis.
Anti-TNF agents are widely accepted treatment for
patients with JIA who not respond to treatment with
DMARD’s. However, the use of anti-TNF or anti-TNF
receptor recombinant fusion monoclonal antibodies (in-
fliximab, etanercept) should be avoided in NBS because of
already present high risk for lymphoma.
In our patient an improvement of arthritis was ob-
served after the use of rituximab. Because of profound
immunodeficiency we did not use rituximab in a high-
dose regimen recommended for treatment of rheuma-
toid arthritis but instead we employed standard dosage
(375 mg/m2) that was safely used in PID. In XLA, a con-
dition with total absence of mature B cells, occurence of
RA has been rarely reported [19,20]. This observation
led to B cell depletion approach with humanized mono-
clonal antibody rituximab in several rheumatic diseases.
In PID, the mechanism of inflammatory, non-infectious
arthritis is not well understood. However, in patients with
PID and severe, chronic arthritis, depletion of synovial B
cells serving as antigen presenting cells to autoreactive T
cell clones may be important [21].
Conclusions
In conclusion, we report on second pediatric patient with
NBS who developed chronic, JIA-like polyarthritis. Non-
infectious, chronic polyarthritis resembling JIA or RA was
the most commonly associated with antibody deficiencies.
An occurrence of inflammatory polyarthritis in NBS rep-
resents a rare, autoimmune feature in this DNA repair
disorder.Note added in proof
At the age of 15 years our patient developed T-cell lym-
phoblastic leukemia/lymphoma (TLBL/ALL) and started
treatment according to the protocol (Berlin-Frankfurth-
Münster, BFM’09 protocol) for standard risk ALL.
Consent
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